Surfing the MASH Tsunami

Aug 09 2024 1020 ep. 25 mins 26

Surfing the MASH Tsunami Podcast artwork

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Health & Fitness Science

Copy RSS

Subscribe on Podcast Addict

S5 - E25 - Reviewing Expert Recommendations on the Use of Resmetirom

Aug 09 2024 42 mins

00:00:00 - Surf's Up: Season 5 Episode 25 On July 20, Clinical Gastroenterology and Hepatology released the paper, Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients with MASH/NASH and Moderate to non-cirrhotic Advanced Fibrosis. Corresponding author Maru Rinella joins the Surfers to share key points from the recommend

S4 - E24.5 - SurfingMASH Question of The Week: Keys to Improving Provider-Patient Communication

Aug 08 2024 20 mins

Two weeks ago, the SurfingMASH Question of the Week asked, "What structural or educational changes do you anticipate will significantly improve Provider-Patient communication? Will these changes require more from the provider and more from the patient?" Today, S5 E23 panelists Mike Betel and José Willemse join Roger Green to review the three answers we received. Of the three quest

S5 - E24.4 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Implications for GLI

Aug 07 2024 18 mins

In the second half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, Jeff discusses the implications of his key EASL Congress takeaways for GLI and other patient advocacy groups. To Jeff, this trend makes patient advocates a more valuable player in the clinical trial design process, particularly when coupled with the FDA's increasi

S5 - E24.3 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Takeaways

Aug 07 2024 12 mins

This conversation contains the first half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, during which the two discuss what Jeff considered the key strategic takeaways for GLI from the various EASL Congress presentations, abstracts and discussions. Jeff focuses on the "overriding sense of optimism" coming from the multiple pieces

S5 - E24.2 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Implications

Aug 07 2024 10 mins

In the second half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean, Matt discusses the implications of his key EASL Congress takeaways for PharmaNest. Matt starts this discussion with a simple question: Will biopsy-based analyses become part of a surrogate endpoint? As he points out, they are not today, and creating the necessary data might require a si

S5 - E24.1 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Takeaways

Aug 07 2024 17 mins

This conversation contains the first half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean. After Matt tells the audience a little about his background and PhramaNest, the two discuss what Matt considered the key strategic takeaways for PharmaNest from the various EASL Congress presentations, abstracts and discussions. Before answering the question, Matt

S5 - E24 - A view of MASLD: Looking back at EASL Congress from six weeks later

Aug 03 2024 76 mins

00:00:00 - Surf's Up: Season 5 Episode 24 This week's episode on MASLD lessons from the EASL Congress 2024 includes three separate elements: individual interviews with PharmaNext Founder and CEO Mathieu Petitjean and Global Liver Institute Vice President of Liver Programs Jeff McIntyre, followed by a discussion with patient advocates Mike Betel of the Fatty Liver Alliance and José

S5 SPECIAL 5 - Reviewing EASL Congress: Louise Campbell 3 (first-time material)

Jul 21 2024 9 mins

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the last day of the Congress This portion of the conversation was not included in the original S5 E19 but instead was reserved for a special conve

S5 SPECIAL 4 - Reviewing EASL Congress: Sven Francque

Jul 20 2024 17 mins

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with Hepatology Key Opinion Leader and EASL Educational Councillor Sven Francque took place 90 minutes after the EASL Congress closed. The discussion focuses on plans and hopes for the future, both the future of MASLD diagnosis and treatment and of t

S5 SPECIAL 3 - Reviewing EASL Congress: Louise Campbell 2

Jul 20 2024 20 mins

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the last day of the Congress.This conversation centered on three major topics addressed at the EASL Congress, each of which made Louise "quite ent